ArticleEuropean radiology2025
Spectral computed tomography-based quantitative parameters combined with extracellular volume fraction to predict lymph node metastases in gastric cancer.
Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Dual-energy computed tomography-derived extracellular volume fraction and spectral quantitative parameters for predicting early recurrence after gastrectomy: insights from a multicenter study.Abdominal radiology (New York) · 2026Article
- Research progress of the clinical application of dual-layer spectral computed tomography in gastrointestinal malignancies.World journal of radiology · 2026Review
- Diagnostic Value of Spectral CT-Derived Extracellular Volume Fraction in the Early Detection of Sigmoid Colon Metastasis from Bladder Cancer: A Case Report.Surgical case reports · 2026Article
- MRI-derived extracellular volume fraction as a prognostic biomarker for early recurrence after R0 resection of pancreatic ductal adenocarcinoma.European journal of radiology open · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
11 authors.
Funding
Abstract
objectivesPreoperative prediction of lymph node metastasis (LNM) is important for gastric cancer (GC) diagnosis, treatment and prognosis. This study aimed to predict LNM risk in GC using quantitative parameters and extracellular volume fraction (ECV%) derived from spectral computed tomography (CT). MATERIALS AND
methodsData from 230 lymph nodes (LNs) (97 nonmetastatic, 133 metastatic) were collected from 70 GC patients and were randomly divided into a training cohort and a test cohort (6:4 ratio). LN qualitative features (including edge, shape and degree of enhancement), spectral CT-derived quantitative parameters and ECV% were assessed. Multivariate logistic regression analysis with the forward variable selection method was used to build 3 models: Model 1 (traditional features: LN edge, short axis diameter), Model 2 (spectral CT parameters: iodine concentration in arterial and delayed phases), and Model 3 (spectral CT parameters and ECV%). Diagnostic performance was evaluated using AUC and compared with the Delong test.
resultsIn both cohorts, a significant difference in ECV% was observed between positive and negative LNs (p < 0.001), and the diagnostic efficacy of ECV% (AUC = 0.823 and 0.803, respectively, both p < 0.001) was higher than that of other parameters. Model 3 demonstrated significantly higher diagnostic efficacy than Models 1 and 2 in both cohorts (AUC = 0.858 and 0.881, respectively; both p < 0.001).
conclusionECV% can help diagnose LNM in GC, and combining the spectral CT quantitative features with ECV% can further improve diagnosis. This finding enables accurate preoperative prediction of LNM and the GC prognosis so that patients receive personalized treatment. KEY POINTS: Question Predicting lymph node metastasis (LNM) based on the LN remains a challenge; can spectral CT combined with the Extracellular volume fraction (ECV%) model predict regional LNM? Findings Based on the LN level, the spectral CT combined ECV% model could more accurately predict regional LNM in the training and test cohort. Clinical relevance Accurate and non-invasive preoperative prediction of LNM in each region is important for the individualized treatment and prognosis of gastric cancer. Assisting physicians in selecting the most appropriate treatment approaches to optimize patient outcomes.
Indexed as
Identifiers
40461708What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.